Atherton Lane Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $1.11M | Buy |
18,711
+6
| +0% | +$355 | 0.06% | 96 |
|
|
2015
Q3 | $1.02M | Sell |
18,705
-3,721
| -17% | -$203K | 0.06% | 98 |
|
|
2015
Q2 | $1.51M | Buy |
22,426
+9,485
| +73% | +$637K | 0.08% | 86 |
|
|
2015
Q1 | $758K | Buy |
12,941
+276
| +2% | +$16.2K | 0.04% | 141 |
|
|
2014
Q4 | $829K | Buy |
12,665
+4
| +0% | +$262 | 0.05% | 143 |
|
|
2014
Q3 | $731K | Sell |
12,661
-194
| -2% | -$11.2K | 0.04% | 154 |
|
|
2014
Q2 | $726K | Buy |
12,855
+405
| +3% | +$22.9K | 0.04% | 155 |
|
|
2014
Q1 | $640K | Sell |
12,450
-680
| -5% | -$35K | 0.04% | 95 |
|
|
2013
Q4 | $693K | Sell |
13,130
-45
| -0.3% | -$2.38K | 0.04% | 90 |
|
|
2013
Q3 | $589K | Buy |
13,175
+1,506
| +13% | +$67.3K | 0.04% | 84 |
|
|
2013
Q2 | $482K | Buy |
+11,669
| New | +$482K | 0.04% | 88 |
|